Here are six recent news updates on gastroenterology and endoscopy companies.
EndoChoice has fulfilled customer orders for its newly-released second generation Fuse system.
EnteroTrack and Denver-based University of Colorado have entered into an exclusive license agreement that will allow EnteroTrack to develop and market a device that monitors gastrointestinal tract inflammation.
Boston Scientific has disclosed insider trading activity — David A. Pierce, senior vice president and president, endoscopy of Boston Scientific unloaded 5,000 shares at an average price of $12.90 on Dec. 8.
Salix Pharmaceuticals announced that Carolyn Logan has decided to retire as president, CEO and a director of the company, effective Jan. 30.
GI Dynamics appointed Michael D. Dale president, CEO and member of the board of directors.
Cantel Medical acquired the assets of Pure Water Solutions for a purchase price of $11.9 million in cash consideration.
More articles on Gi/endoscopy:
EndoChoice releases second generation Fuse system
EnteroTrack, University of Colorado partner on GI tract inflammation monitoring device
Dr. Brett Hassan joins Milford Regional Medical Center